Navigation Links
Researchers find new target for stopping tumors developing their own blood supply
Date:11/18/2010

Researchers have found that a newly developed drug, which is aimed at a particular receptor involved in the development of blood vessels that sustain tumour growth, is active in patients with advanced cancers and, in some cases, has halted the progress of the disease. The drug, ACE-041, targets a different molecular pathway to other anti-angiogenesis drugs and may provide a new option to treat cancer.

Results from a phase I clinical study of ACE-041 were presented at the 22nd EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Berlin today (Friday). The drug targets a receptor known as activin receptor-like kinase-1 (ALK-1), which regulates the formation of new networks of blood vessels needed for tumour growth a process known as angiogenesis. While existing anti-angiogenic drugs such as bevacizumab, sunitinib and sorafenib target other angiogenesis receptors such as VEGF, ACE-041 is one of the first to target the ALK-1 pathway.

Professor Sunil Sharma, the Jon and Karen Huntsman Presidential Professor of Cancer Research at the Huntsman Cancer Institute, University of Utah, Salt Lake City (USA), told the meeting that the connection of ALK-1 with angiogenesis was made with the discovery that mutations in the ALK-1 gene caused a condition known as hereditary haemorrhagic telangiectasia 2 (HHT2), which is characterised by impaired formation of capillary beds and causes red markings on the skin.

Acceleron Pharma, a biotechnology company in Cambridge, Massachusetts (USA), designed ACE-041 to inhibit ALK-1 signalling and asked Prof Sharma to be one of the investigators to conduct the first-in-man phase I clinical trial of the drug to see if it would inhibit tumour angiogenesis.

"Since ALK-1 is only transiently expressed on proliferating endothelial cells (the cells that line the inner surface of blood vessels), in contrast to the VEGF receptors which are constitutively expressed on endothelial and other c
'/>"/>

Contact: Emma Mason
wordmason@mac.om
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Researchers identify PTSD measures for use in traumatic brain injury research
2. New insight into the cause of common dementia found by researchers at Mayo Clinic
3. Researchers fight Americas other drug problem
4. Researchers map the way to personalised treatment for ovarian cancer
5. Four NYU researchers receive New York Academy of Sciences 2010 Young Scientists awards
6. AAPS presents awards to exemplary researchers
7. Yerkes researchers present at 40th Annual Society for Neuroscience Conference
8. Researchers see ethical dilemmas of providing care in drug detention centers
9. Circuit regulating anti-diabetic actions of serotonin uncovered by UT Southwestern researchers
10. U of M researchers find learning in the visual brain
11. Researchers discover important link between adrenal gland hormone and brain in hypertension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... is a leading review website in the world. It ... announced that GreenGeeks, Arvixe and Hostgator are the best ... http://www.greengeeks.com/cgi-bin/affiliates/clickthru.cgi?id=seohosts ) is one of the best web hosting ... of useful products for sale. On its website, customers ... , As one of the Top 10 Web Hosting ...
(Date:9/1/2014)... may be bad for your waistline. TV viewers ate ... excerpt from a Hollywood action film than those watching ... for helping Americans to gain weight because it encourages ... been on the medium and not the message. TV ... to eat more, including reading, listening to the radio ...
(Date:9/1/2014)... 1, 2014 (HealthDay News) -- You may be able to ... ones, new research suggests. The study included eight overweight ... weight-loss program meant to change how people react to different ... five overweight and obese people who weren,t in the program. ... of the study and again six months later. The scans ...
(Date:9/1/2014)... Albany, New York (PRWEB) September 01, 2014 ... specially-fitted room in a hospital for performing surgical operations. ... such as operating tables, surgical booms, operating room lights, ... rooms. According to a report by Transparency Market Research, ... market is expected to reach USD 4.5 billion by ...
(Date:9/1/2014)... HealthDay Reporter FRIDAY, Aug. 29, 2014 (HealthDay ... American aid workers successfully cured a group of monkeys infected ... The drug, ZMapp, prompted recovery in all 18 monkeys who ... five days after infection. ZMapp even cured monkeys with ... away from death, said study senior author Gary Kobinger, chief ...
Breaking Medicine News(10 mins):Health News:The Best Reseller Hosting Suppliers in August Released by Leading Review SiteTop10BestSEOHosting.com 2Health News:Research letter: Viewers ate more while watching Hollywood action flick on TV 2Health News:Train Your Brain to Choose Fruit Salad Over French Fries 2Health News:Operating Room Equipment Market Study 2019 by Transparency Market Research 2Health News:Operating Room Equipment Market Study 2019 by Transparency Market Research 3Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 2Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 3
... Two new vitamin D studies using a sophisticated form of ... combined, have revealed new prescriptions for// possibly preventing up to ... the cases of colorectal cancer in the United States. The ... specialists at the Moores Cancer Center at University of California, ...
... older men experience the symptoms of an enlarged prostate multiple ... know is that the disease// known as BPH (benign prostatic ... but at least a pair of disorders, and that one ... — has far more serious implications. ,In a ...
... not sound like such a bad thing. But a condition ... PCOS – can present women with numerous health concerns, ranging ... risk of heart disease and diabetes. ,PCOS affects ... one of the more common hormonal abnormalities women experience during ...
... use for checking body temperature is most lethal and ... ,Mercury is a neurotoxin, meaning it attacks the ... has been linked to birth defects, learning disabilities, walking ... ,In adults, mercury poisoning leads to tremors, headaches, ...
... of launching an oral vaccine for diabetes that would ... to millions in the country// suffering from the debilitating ... Transgene Biotek Ltd is currently doing research and pre-clinical ... Institute of Chemical Technology (IICT), Hyderabad. ,"We ...
... dead pregnant woman on life support had passed the milestone ... outside the womb, giving her family new hope. The family ... was a possible name the couple had discussed before her ... have assumed an important criterion in the use and abuse ...
Cached Medicine News:Health News:Two New Studies Back Vitamin D for Cancer Prevention 2Health News:Two New Studies Back Vitamin D for Cancer Prevention 3Health News:Severe Form of “Enlarged Prostate” Disease Discover 2Health News:Condition That Causes Irregular Periods Can Lead to Fertility Problems 2Health News:Condition That Causes Irregular Periods Can Lead to Fertility Problems 3Health News:Mercury can Kill 2Health News:Mercury can Kill 3Health News:India Developing Oral Vaccine to Fight Diabetes 2Health News:Ultrasound Technology - Boon or a Bane? 2Health News:Ultrasound Technology - Boon or a Bane? 3Health News:Ultrasound Technology - Boon or a Bane? 4
(Date:8/29/2014)... , Aug. 29, 2014  United Therapeutics Corporation (NASDAQ: ... District Court for the District of New ... the company,s case against Sandoz, Inc. regarding United Therapeutics, ... Sheridan ruled that U.S. Patent No. 6,765,117 is ... Sandoz from marketing its generic product until the expiration ...
(Date:8/29/2014)... , August 29, 2014 ... Market by Product & Services (Equipment, Reagent, Primer, ... Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, ... MarketsandMarkets, the global Oligonucleotide Synthesis Market is expected ... Million in 2014, growing at a CAGR of ...
(Date:8/29/2014)... Aug. 29, 2014  Unilife Corporation ("Unilife" or "Company") ... that it intends to release its financial results for ... 30, 2014 after market trading ends on Tuesday, September ... conference call for 4:30 p.m. U.S. EDT on Tuesday, ... a.m. AEST), to review the Company,s financial results, commercial partnerships, ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2
...
Cobb Curettes, reverse angled, 11"....
Malis Needle Holders, bayonet, titanium. Working distance 2 1/2" (63 mm). Straight tip with width 0.6 mm....
Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Medicine Products: